603811: Zhejiang Cheng Yi Pharmaceutical Co., Ltd. - Summary | Jitta

Zhejiang Cheng Yi Pharmaceutical Co., Ltd.

CHN:603811

Price
CN¥6.99
Loss Chance
42.4%
6.72JITTA SCORE
24.30%Over Jitta Line
Jitta Ranking
260 / 486
2,716 / 5,282
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (53)
Recent Business Performance (41)
Financial Strength (92)
Return to Shareholders (72)
Competitive Advantage (59)
Jitta Signs
Revenue and EarningConsistent
Debt LevelLow Long Term Debt
Dividend PayoutIncreasing Every Year
Interest Coverage RatioVery Good
SG&A to SalesDecreasing
Recent Business PerformanceEarning decline 22.75% in the last quarter (yoy)
Key Stats
Jitta Score
Jitta Line
6.72
24.30%
4.36
818.87%
4.22
> 1,000%
Pharmaceuticals
7.05
2.44%
7.28
22.49%
7.98
39.87%
COMPANY DESCRIPTION
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. engages in the research, development, production, and sales of formulations and active pharmaceutical ingredients in China and internationally. The company offers glucosamine hydrochloride raw materials and preparations, gastrodin raw materials, ribavirin preparations raw materials, and sulfur dioxide raw materials. It also provides injections, food, capsules, tablets, traditional Chinese medicines, preparations, and intermediates; and joint-related drugs, diuretics and antihypertensive drugs, antiviral drugs, antitumor drugs, vitamins, and sedative and brain-boosting drugs, as well as other health products and medical instruments. The company was formerly known as Wenzhou No. 3 Pharmaceutical Factory and changed its name to Zhejiang Cheng Yi Pharmaceutical Co., Ltd. in April 2001. Zhejiang Cheng Yi Pharmaceutical Co., Ltd. was founded in 1966 and is based in Shanghai, China.